Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
66,399,673
-
Total 13F shares
-
132,138
-
Share change
-
-294,503
-
Total reported value
-
$14,144,788
-
Price per share
-
$107.04
-
Number of holders
-
24
-
Value change
-
-$30,005,965
-
Number of buys
-
11
-
Number of sells
-
9
Institutional Holders of RHYTHM PHARMACEUTICALS, INC. - COM (RYTM) as of Q4 2025
As of 31 Dec 2025,
RHYTHM PHARMACEUTICALS, INC. - COM (RYTM) was held by
24 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
132,138 shares.
The largest 10 holders included
HARBOR CAPITAL ADVISORS, INC., WEDGE CAPITAL MANAGEMENT L L P/NC, NISA INVESTMENT ADVISORS, LLC, SG Americas Securities, LLC, Hennion & Walsh Asset Management, Inc., TOTH FINANCIAL ADVISORY CORP, Leo Wealth, LLC, E. Ohman J:or Asset Management AB, EXCHANGE TRADED CONCEPTS, LLC, and Avior Wealth Management, LLC.
This page lists
24
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.